Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT05241249

Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic Adenocarcinoma

Led by Susan E. Bates · Updated on 2025-06-05

37

Participants Needed

1

Research Sites

204 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The primary objective of this study is to assess the impact of bethanechol therapy on R0 resection rates. The safety objective will be assessment of the safety and tolerability of bethanechol in combination with gemcitabine and nab-paclitaxel. The exploratory objective will be to evaluate genomic biomarkers associated with parasympathetic stimulation in pancreatic cancer, and the ability to reduce tumor growth rate.

CONDITIONS

Official Title

Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic Adenocarcinoma

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of pancreatic ductal adenocarcinoma
  • Plan to receive neoadjuvant chemotherapy
  • Diagnostic tissue available for biomarker analysis
  • Ability to take oral medications and follow study procedures
Not Eligible

You will not qualify if you...

  • Presence of metastatic disease
  • Evidence of gastrointestinal obstruction
  • Baseline slow heart rate (heart rate less than 55) or low blood pressure (systolic under 90)
  • Current use of acetylcholinesterase inhibitors
  • Medical conditions including hyperthyroidism, active or symptomatic coronary artery disease, seizure disorder, or peptic ulcer disease

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Columbia University Medical Center

New York, New York, United States, 10032

Actively Recruiting

Loading map...

Research Team

R

Research Nurse Navigator

CONTACT

S

Susan E Bates, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

OTHER

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here